"EvergreenHealth Multiple Sclerosis Services provides services in Kirkland, WA. We offer a state-of-the-art facility with patient-friendly access, an on-site clinical research lab, and comprehensive rehabilitation services."

During the past decade, MS Center at Evergreen conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MS Center at Evergreen" #1 sponsor was "Acorda Therapeutics" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Opexa Therapeutics, Inc." with 2 trials sponsored and "Artielle ImmunoTherapeutics" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MS Center at Evergreen" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "MS Center at Evergreen" are "Multiple Sclerosis" (10 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Clinically Isolated Syndrome" (1 trials) and "Multiple Sclerosis, Chronic Progressive" (1 trials). Many other conditions were trialed in "MS Center at Evergreen" in a lesser frequency.

Most popular intervention types in "MS Center at Evergreen" are "Drug" (14 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Fampridine-SR" (3 trials), "Cladribine Tablets" (2 trials), "Fenebrutinib" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "MS Center at Evergreen" are 16 trials for "All" genders.

Currently, there are NaN active trials in "MS Center at Evergreen". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in MS Center at Evergreen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MS Center at Evergreen, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".